Actinium Pharmaceuticals

Actinium Pharmaceuticals

Biotechnology, 275 Madison Ave, New York, 10016, United States, 11-50 Employees

actiniumpharma.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 64********

Who is ACTINIUM PHARMACEUTICALS

Actinium Pharmaceuticals (NYSE: ATNM) is focused on developing innovative targeted radioimmunotherapies for the treatment of advanced cancers. Currently Investigating therapies in #AML an...

Read More

map
  • 275 Madison Ave, New York, New York, 10016, United States Headquarters: 275 Madison Ave, New York, New York, 10016, United States
  • 2000 Date Founded: 2000
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $50 Million to $100 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 541910 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ACTINIUM PHARMACEUTICALS

Actinium Pharmaceuticals Org Chart and Mapping

Employees

Umar Syed

Clinical Trial Manager

Garth Parham

Business Development Manager

Le-Cun Xu

Senior Principal Scientist

Jason Scott

Medical Sales Representative

Jason Li

Senior Research Associate

Betsy King

Director, Quality and Regulatory Affairs

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Actinium Pharmaceuticals

Answer: Actinium Pharmaceuticals's headquarters are located at 275 Madison Ave, New York, 10016, United States

Answer: Actinium Pharmaceuticals's phone number is 64********

Answer: Actinium Pharmaceuticals's official website is https://actiniumpharma.com

Answer: Actinium Pharmaceuticals's revenue is $50 Million to $100 Million

Answer: Actinium Pharmaceuticals's SIC: 2834

Answer: Actinium Pharmaceuticals's NAICS: 541910

Answer: Actinium Pharmaceuticals has 11-50 employees

Answer: Actinium Pharmaceuticals is in Biotechnology

Answer: Actinium Pharmaceuticals contact info: Phone number: 64******** Website: https://actiniumpharma.com

Answer: Actinium Pharmaceuticals (NYSE: ATNM) is focused on developing innovative targeted radioimmunotherapies for the treatment of advanced cancers. Currently Investigating therapies in #AML and #BMT

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access